CompletedNCT01632189
Varenicline and Dopamine Receptors in People Who Smoke
About this title
Read the official source — NCT01632189Medication studyAges 21–45CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 45 years.
- Listed locations
- TorontoSee all locations and recruitment
Study information
Study start dateSeptember 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 21 Years to 45 Years
- Official registry ID
- NCT01632189
- Official title
Show the full official title
Investigating the Effects of Varenicline on D2/3 Receptor Binding in Brain of Tobacco-smokers: a PET/[11C](+)PHNO Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Varenicline.
Who was this study for?
Listed age limits: 21 years to 45 years.
